Labcorp said members of its executive management team will present at the 44th Annual William Blair Growth Stock Conference on Tuesday, June 4 at 2:00 p.m. (CT), it said on May 28, 2024.

8-KRegulation FD DisclosureFiled May 28, 2024Period of report May 28, 2024Summary published (UTC) Oct 26, 2026

Key points

AI summary

Labcorp said members of its executive management team will present at the 44th Annual William Blair Growth Stock Conference on Tuesday, June 4 at 2:00 p.m. (CT), it said on May 28, 2024.
Labcorp described itself as a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions.
The company said more than 67,000 employees serve clients in approximately 100 countries.
Labcorp said it provided support for 84% of the new drugs and therapeutic products approved by the FDA in 2023, and performed more than 600 million tests for patients around the world.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Labcorp Speaks at William Blair Growth Stock Conference

Labcorp said members of its executive management team will present at the 44th Annual William Blair Growth Stock Conference on Tuesday, June 4 at 2:00 p.m. (CT), it said on May 28, 2024.

Source · Based on the filing body and exhibits

Company Overview: Diagnostics and Drug Development Lab Services

Labcorp described itself as a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions.

Source · Based on the filing body and exhibits

Employee Count and Service Reach

The company said more than 67,000 employees serve clients in approximately 100 countries.

Source · Based on the filing body and exhibits

Support for FDA-Approved Drugs and Test Volume

Labcorp said it provided support for 84% of the new drugs and therapeutic products approved by the FDA in 2023, and performed more than 600 million tests for patients around the world.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.